An Attacking Portfolio For The Growing Defense Theme.
, the $73 billion Indian defence market provides rich opportunities. Further,
the DPEPP 2020 and Make in India initiative (Atmanirbhar Bharat) provides ample opportunities for the Indian defence
manufacturers to not only replace foreign defence manufacturers providing supplies to Indian armed forces, but also to focus
on exports to other friendly or neutral countries. This provides a large TAM.
These companies have persistent competitive advantages because of highly specialized capabilities, strong, cash-rich balance
sheets to power their growth, ample cash flows and are available at significant discount to their intrinsic values. This is a
SuperNormal Portfolio of defence companies.
OmniScience Capital Advisors Private Limited (OmniScience Investment Advisers) is a Registered Investment Advisory firm with SEBI-registration no. INA000007623. Equity investments are subject to market risks. Please read all related documents carefully. An investor should consider the investment objectives, risks, and charges & expenses carefully before taking any investment decision. This is not an offer document.
Accept terms and conditions to view this page.To know more Click Here.